Answers are grounded in this paper and cite their sources.
With NGS and CRISPR/Cas9, the goal is no longer to match the treatment for the diagnosed tumor but rather to build a treatment method that fits the tumor exactly. Hence, in this review, we have discussed the potential role of CRISPR/Cas9 and NGS in advancing personalized medicine.
No takes yet. Share an insight, caveat, or question.
Selvakumar et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: